-transparent.png){kind=logo}
Most superficial bladder tumors are best treated by transurethral resection. However, because of their multifocal origin and high rate of recurrence they often present challenging therapeutic problems. Intravesical chemotherapy often is used in such cases in the treatment and prevention of recurrent transitional cell carcinoma of the bladder. Recently, mitomycin C intravesical chemotherapy was shown to be effective in the treatment of superficial bladder tumors. No systemic toxicities were described but bladder irritation and drug-related palmar desquamation were noted. We report a case of a severely contracted bladder requiring urinary diversion following intravesical chemotherapy with mitomycin C. A possible relationship of this complication to the mitomycin C treatment is suggested.
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
November 1988,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
September 1985,
International journal of dermatology,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
April 2002,
The Journal of urology,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
January 1989,
Progress in clinical and biological research,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
April 2014,
Nature reviews. Urology,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
January 2006,
Mymensingh medical journal : MMJ,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
March 1984,
Cancer,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
December 2006,
The Canadian journal of urology,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
November 2012,
Gan to kagaku ryoho. Cancer & chemotherapy,
Z Wajsman, and
W McGill, and
L Englander, and
R P Huben, and
J E Pontes
June 1996,
Urology,
